Article
In silico prediction of ARB resistance: A first step in creating personalized ARB therapy
2020-02-12
Abstract excerpt
Angiotensin II type 1 receptor (AT 1 R) blockers (ARBs) are among the most prescribed drugs. However, ARB effectiveness varies widely, and some patients do not respond to ARB therapy. One reason for the variability between patients is non-synonymous single nucleotide polymorphisms (nsSNPs) within agtr1 , the AT 1 R gene. There are over 100 nsSNPs in the AT 1 R; therefore, this study embarked on determining whi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2b847811-a7ee-5ebd-ab5f-c7ba439d5bf3
- DOI
- 10.1101/2020.02.12.945402
